Johnson & Johnson
$250.57-2.47Marktkapitalisatie
$653.3B
Wereldwijde rang
#21
Recordhoogte
$653.3B
2026-08-18
Totale groei
+0%
sinds 2026
Market Cap Context
- Larger than 94% of the 367 companies we track (globally).
- Equivalent to 2.1% of United States's GDP (2025 data).
- Just above: #20 ExxonMobil ($680.8B)
- Just below: #22 Visa ($620.7B)
- Best year: 1995 (+59%). Worst year: 2023 (-9%).
Johnson & Johnson Financial Breakdown (FY 2025)
Source: Yahoo Finance โ JNJ annual filings (2025) โ$94.2B revenue ยท $25.6B operating income ยท $26.8B net income
- โOperating margin: 27.2% on $94.2B in revenue.
- โR&D is 15.6% of revenue ($14.7B).
- โNet income margin: 28.5% โ $26.8B in profit.
- โFree cash flow: $19.3B (20.5% of revenue).
Cost / Operating Expenses
Total operating expenses $68.6B
Total
$68.6B
Capital Expenditures
$5.2B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$19.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
28.9
EPS
$8.60
Net margin
21.8%
ROE
26.3%
Dividend yield
2.09%
Debt / Equity
0.68
Over Johnson & Johnson
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
Marktkapitalisatiegeschiedenis van Johnson & Johnson (2026โ2026)
Johnson & Johnson vs Sector Peers by Market Cap
Johnson & Johnson vergelijken
Ranggeschiedenis
| Jaar | Marktkapitalisatie | Rang | Verandering op jaarbasis |
|---|---|---|---|
| 2026 | $653.3B | #21(โ1) | +32.6% |
| 2025 | $492.7B | #20(โ5) | +47.5% |
| 2024 | $334.1B | #25(โ5) | -4.8% |
| 2023 | $351.0B | #20(โ10) | -8.6% |
| 2022 | $383.9B | #10(โ5) | +6.0% |
| 2021 | $362.3B | #15(โ1) | +11.4% |
| 2020 | $325.1B | #14(โ1) | +10.8% |
| 2019 | $293.3B | #13(โ4) | +16.2% |
| 2018 | $252.4B | #9 | -5.1% |
| 2017 | $266.0B | #9(โ1) | +24.4% |
| 2016 | $213.8B | #8(โ1) | +15.3% |
| 2015 | $185.4B | #7(โ1) | +1.1% |
| 2014 | $183.3B | #6(โ2) | +17.3% |
| 2013 | $156.2B | #8(โ1) | +34.6% |
| 2012 | $116.0B | #9(โ2) | +10.8% |
| 2011 | $104.7B | #7(โ3) | +9.9% |
| 2010 | $95.3B | #10(โ6) | -0.6% |
| 2009 | $95.8B | #4(โ3) | +11.3% |
| 2008 | $86.1B | #7(โ5) | -7.7% |
| 2007 | $93.3B | #12(โ4) | +3.6% |
| 2006 | $90.1B | #8(โ1) | +12.4% |
| 2005 | $80.1B | #9 | -3.4% |
| 2004 | $82.9B | #9(โ2) | +25.2% |
| 2003 | $66.2B | #11(โ3) | -2.1% |
| 2002 | $67.6B | #8(โ3) | -7.9% |
| 2001 | $73.4B | #11(โ4) | +14.0% |
| 2000 | $64.4B | #15(โ3) | +14.2% |
| 1999 | $56.4B | #18(โ2) | +12.5% |
| 1998 | $50.1B | #16(โ1) | +29.0% |
| 1997 | $38.9B | #17(โ1) | +34.3% |
| 1996 | $28.9B | #16(โ4) | +18.1% |
| 1995 | $24.5B | #12(โ3) | +59.1% |
| 1994 | $15.4B | #15 |
Andere bedrijven in de sector Gezondheidszorg
Veelgestelde vragen
What is Johnson & Johnson's market cap?
Johnson & Johnson (JNJ) has a market capitalization of $653.3B, making it the #21 largest company in the world by market cap.
What was Johnson & Johnson's highest market cap?
Johnson & Johnson's all-time high market cap was $653.3B, reached in 2026-08-18. Its highest rank was #21 in 2026.
What sector is Johnson & Johnson in?
Johnson & Johnson is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Johnson & Johnson's market cap changed over time?
Johnson & Johnson has been tracked since 2026. Its market cap has grown by 0% from $653.3B in 2026 to $653.3B today.